Compounds > 17-ethynyl-5-estrane-3,17-diol
Page last updated: 2024-09-04

17-ethynyl-5-estrane-3,17-diol and 5 alpha-dihydronorethindrone

17-ethynyl-5-estrane-3,17-diol has been researched along with 5 alpha-dihydronorethindrone in 1 studies

Compound Research Comparison

Studies
(17-ethynyl-5-estrane-3,17-diol)		Trials
(17-ethynyl-5-estrane-3,17-diol)		Recent Studies (post-2010)
(17-ethynyl-5-estrane-3,17-diol)		Studies
(5 alpha-dihydronorethindrone)		Trials
(5 alpha-dihydronorethindrone)		Recent Studies (post-2010) (5 alpha-dihydronorethindrone)
501600

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García, GA; Garza-Flores, J; Menjívar, M; Pérez-Palacios, G; Vilchis, F1

Other Studies

1 other study(ies) available for 17-ethynyl-5-estrane-3,17-diol and 5 alpha-dihydronorethindrone

ArticleYear
A-ring reduction enhances the antigonadotropic potency of norethisterone.
    Acta endocrinologica, 1986, Volume: 112, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Isomerism; Luteinizing Hormone; Male; Norethindrone; Norethynodrel; Orchiectomy; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1986